Interesting ImagesComparison of 68Ga-FAPI and 18F-FDG PET/CT in a Patient With Cholangiocellular Carcinoma A Case ReportPang, Yizhen MD; Hao, Bing MD; Shang, Qihang MD; Sun, Long MD, PhD; Chen, Haojun MD, PhDAuthor Information From the Department of Nuclear Medicine & Minnan PET Center, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, China. Received for publication January 15, 2020; revision accepted March 7, 2020. Conflicts of interest and sources of funding: none declared. Correspondence to: Haojun Chen, MD, PhD, 55 Zhenhai Road, Xiamen 361003, China. E-mail: firstname.lastname@example.org. Clinical Nuclear Medicine: July 2020 - Volume 45 - Issue 7 - p 566-567 doi: 10.1097/RLU.0000000000003056 Buy Metrics Abstract The present study compared 68Ga-FAPI and 18F-FDG PET/CT in a patient with cholangiocellular carcinoma. In this case, 68Ga-FAPI PET shows much higher tumor-to-background contrast of primary tumor and reveals more metastatic lesions, especially the micrometastases of bones, than 18F-FDG PET. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.